A Clinical Trial to Evaluate the Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects

Trial Profile

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs NVP 1402 (Primary)
  • Indications CNS disorders
  • Focus Pharmacokinetics
  • Sponsors Navipharm
  • Most Recent Events

    • 06 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 29 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 29 Dec 2016 Planned End Date changed from 1 Apr 2017 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top